News

During the third trimester, you’ll see your doctor more frequently to check for signs of preterm labor and to assess your ...
Kristen Stone-Mulhern (left) and Christine A. Talmage (right), providers at St. Luke's OB/GYN facility in Center Valley. Photos courtesy of St. Luke's. CENTER VALLEY, Pa. - St. Luke’s University ...
Proponents of eating the placenta say the practice has benefits — but there are risks, too. Here's what you need to know.
PROVO — The number of criminal cases filed against a former Provo OB-GYN accused of sexually abusing patients under the guise of medical exams keeps growing. On Friday, David Harrison Broadbent ...
Wanakee Carr's first day in an OB-GYN unit went something like this: Hey, do you want to deliver a baby? Yeah. How else are you going to know if you're interested in it or not? It was 2012 ...
Dr. Christopher Stroud was a Catholic OB-GYN who prescribed birth control and gave referrals for in vitro fertilization (IVF) until a priest admonished him in the sacrament of reconciliation.
Feb. 26, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services, today announced that OB/GYN ...
She was diagnosed with Guillain-Barré syndrome, or GBS, a rare autoimmune disorder in which the body's immune system attacks its nerves, causing muscle weakness and varying degrees of paralysis. 32 ...
Babies at greater risk of infection and serious disease from GBS are typically those born preterm or with low birth weight. While this is still very scary, Sarah Bjorkman, MD, OB-GYN and Motherly’s ...
Your OB/GYN will also estimate the due date for delivery ... American College of Obstetricians and Gynecologists. Group B strep and pregnancy. American College of Obstetricians and Gynecologists.
After feeling dismissed by a doctor, she started bringing her husband, Phin, to her OB-GYN appointments. She shares her experience with one of TODAY's health reporters in the following essay.
To assess the risk of GBS with these vaccines, the FDA conducted a postmarketing observational study that used Medicare claims data between May 2023 and July 2024. Individuals aged 65 years and ...